Header Logo

Connection

BIYKEM BOZKURT to Treatment Outcome

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Treatment Outcome.
BIYKEM BOZKURT
Connection Strength
0.890
Treatment Outcome
  1. Contemporary pharmacological treatment and management of heart failure. Nat Rev Cardiol. 2024 08; 21(8):545-555.
    View in: PubMed
    Score: 0.069
  2. Successful Decongestion as a Clinical Target, Performance Indicator, and as a Study Endpoint in Hospitalized Heart Failure Patients. JACC Heart Fail. 2023 01; 11(1):126-129.
    View in: PubMed
    Score: 0.063
  3. Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J Card Fail. 2002 Oct; 8(5):306-14.
    View in: PubMed
    Score: 0.062
  4. Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
    View in: PubMed
    Score: 0.062
  5. Cardiac Rehabilitation for Patients With?Heart?Failure: JACC Expert Panel. J Am Coll Cardiol. 2021 03 23; 77(11):1454-1469.
    View in: PubMed
    Score: 0.056
  6. Heart Failure in Women. Methodist Debakey Cardiovasc J. 2017 Oct-Dec; 13(4):216-223.
    View in: PubMed
    Score: 0.044
  7. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
    View in: PubMed
    Score: 0.030
  8. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.029
  9. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.028
  10. Where do we currently stand with advice on hormone replacement therapy for women? Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan; 6(4):21-5.
    View in: PubMed
    Score: 0.027
  11. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
    View in: PubMed
    Score: 0.026
  12. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
    View in: PubMed
    Score: 0.025
  13. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
    View in: PubMed
    Score: 0.024
  14. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Am J Cardiol. 2008 Nov 15; 102(10):1356-60.
    View in: PubMed
    Score: 0.023
  15. Baseline characteristics in the SYNCHRONIZE?-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes. Diabetes Obes Metab. 2026 Feb; 28(2):1490-1498.
    View in: PubMed
    Score: 0.019
  16. Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE?-1). Diabetes Obes Metab. 2026 Jan; 28(1):337-346.
    View in: PubMed
    Score: 0.019
  17. Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure. JACC Heart Fail. 2025 Oct; 13(10):102515.
    View in: PubMed
    Score: 0.019
  18. Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints. J Cardiovasc Magn Reson. 2025; 27(1):101121.
    View in: PubMed
    Score: 0.018
  19. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. Circ Cardiovasc Qual Outcomes. 2024 Sep; 17(9):e000132.
    View in: PubMed
    Score: 0.018
  20. JACC Journals' Pathway Forward With?AI Tools: The Future Is Now. JACC Cardiovasc Interv. 2023 04 10; 16(7):881-883.
    View in: PubMed
    Score: 0.016
  21. Design of the remede System Therapy (reST) study: A prospective non-randomized post-market study collecting clinical data on safety and effectiveness of the remede system for the treatment of central sleep apnea. Sleep Med. 2022 12; 100:238-243.
    View in: PubMed
    Score: 0.015
  22. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. J Thorac Cardiovasc Surg. 2021 Sep; 162(3):829-850.e1.
    View in: PubMed
    Score: 0.014
  23. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001 Feb 27; 103(8):1044-7.
    View in: PubMed
    Score: 0.014
  24. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999 Jul; 34(1):177-80.
    View in: PubMed
    Score: 0.012
  25. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e698-e800.
    View in: PubMed
    Score: 0.012
  26. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e637-e697.
    View in: PubMed
    Score: 0.012
  27. Lifestyle Modifications for Preventing?and Treating Heart?Failure. J Am Coll Cardiol. 2018 11 06; 72(19):2391-2405.
    View in: PubMed
    Score: 0.012
  28. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.012
  29. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med. 2017 06; 22(3):NP1-NP43.
    View in: PubMed
    Score: 0.011
  30. Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T. Respir Res. 2015 Oct 16; 16:126.
    View in: PubMed
    Score: 0.010
  31. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Nucl Cardiol. 2015 Oct; 22(5):1041-144.
    View in: PubMed
    Score: 0.010
  32. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Circulation. 2015 Jul 28; 132(4):302-61.
    View in: PubMed
    Score: 0.009
  33. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):e5-23.
    View in: PubMed
    Score: 0.009
  34. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility. JAMA Surg. 2013 Dec; 148(12):1087-93.
    View in: PubMed
    Score: 0.008
  35. Transcatheter aortic valve replacement as a treatment for late apicoaortic conduit obstruction in a patient with severe aortic stenosis. Circulation. 2013 Mar 19; 127(11):e491-4.
    View in: PubMed
    Score: 0.008
  36. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82.
    View in: PubMed
    Score: 0.008
  37. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan; 4(1):53-8.
    View in: PubMed
    Score: 0.007
  38. Does the level of experience of residents affect outcomes of coronary artery bypass surgery? Ann Thorac Surg. 2009 Apr; 87(4):1127-33; discussion 1133-4.
    View in: PubMed
    Score: 0.006
  39. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008 Dec 16; 118(25):2803-10.
    View in: PubMed
    Score: 0.006
  40. Does the use of bilateral internal mammary artery grafts impact survival of veterans undergoing coronary artery bypass surgery? Am J Surg. 2008 Nov; 196(5):726-31.
    View in: PubMed
    Score: 0.006
  41. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
    View in: PubMed
    Score: 0.005
  42. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
    View in: PubMed
    Score: 0.003
  43. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.